Production (Stage)
Acumen Pharmaceuticals, Inc.
ABOS
$1.02
-$0.01-0.97%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -13.06% | -14.37% | -23.08% | 3.15% | 3.69% |
Total Receivables | 12.58% | 96.87% | 200.94% | -43.92% | -52.75% |
Inventory | -- | 11.19% | 18.18% | -2.42% | 26.53% |
Prepaid Expenses | -43.94% | -15.13% | 964.21% | -76.89% | -49.07% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -9.66% | -12.24% | -4.98% | 135.88% | 45.13% |
Total Current Assets | -13.10% | -14.12% | -22.21% | 4.33% | 3.74% |
|
|||||
Total Current Assets | -13.10% | -14.12% | -22.21% | 4.33% | 3.74% |
Net Property, Plant & Equipment | 10.03% | -11.95% | -10.47% | -8.51% | -6.56% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -1.08% | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -19.00% | -6.65% | -14.71% | 27.96% | -18.06% |
Total Assets | -14.44% | -10.48% | -7.59% | -4.01% | -2.95% |
|
|||||
Total Accounts Payable | -81.30% | 141.16% | -44.38% | 36.77% | 123.28% |
Total Accrued Expenses | -18.03% | 25.25% | 58.45% | 127.13% | -54.43% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 3.76% | 3.10% | 3.20% | 3.31% | -86.03% |
Total Finance Division Other Current Liabilities | 81.74% | 14.43% | 34.90% | -69.02% | 126.89% |
Total Other Current Liabilities | 81.74% | 14.43% | 34.90% | -69.02% | 126.89% |
Total Current Liabilities | -30.04% | 38.63% | 29.59% | 81.39% | -34.69% |
|
|||||
Total Current Liabilities | -30.04% | 38.63% | 29.59% | 81.39% | -34.69% |
Long-Term Debt | 0.37% | -0.86% | 1.00% | -2.74% | 1.04% |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -24.00% | -18.92% | -15.53% | -13.10% | -11.27% |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | -14.37% | 14.87% | 10.69% | 15.50% | -9.78% |
|
|||||
Common Stock & APIC | 0.48% | 0.46% | 0.47% | 0.49% | 2.12% |
Retained Earnings | -8.86% | -12.90% | -11.53% | -8.64% | -6.68% |
Treasury Stock & Other | 131.25% | -109.27% | 415.85% | -13.89% | -146.15% |
Total Common Equity | -14.46% | -16.29% | -10.96% | -6.90% | -1.85% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -14.46% | -16.29% | -10.96% | -6.90% | -1.85% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -14.46% | -16.29% | -10.96% | -6.90% | -1.85% |
|